Adelaide Research & Scholarship: Search

Search

Results 1-7 of 7 (Search time: 0.005 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2003	Polymorphic hydroxylation of perhexiline in vitro	Sorensen, L.; Sorensen, R.; Miners, J.; Somogyi, A.; Grgurinovich, N.; Birkett, D.
	2009	Associations between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with Tamoxifen	Schroth, W.; Goetz, M.; Hamann, U.; Fasching, P.; Schmidt, M.; Winter, S.; Fritz, P.; Simon, W.; Suman, V.; Ames, M.; Safgren, S.; Kuffel, M.; Ulmer, H.; Bolander, J.; Strick, R.; Beckmann, M.; Koelbl, H.; Weinshilboum, R.; Ingle, J.; Eichelbaum, M.; et al.
	2007	Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia	Inglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.
	2002	Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters	Glaeser, H.; Drescher, S.; Van der Kuip, H.; Behrens, C.; Geick, A.; Burk, O.; Dent, J.; Somogyi, A.; von Richter, O.; Griese, E.; Eichelbaum, M.; Fromm, M.
	1997	Association between CYP2C19 genotype and proguanil oxidative polymorphism.	Coller, J.; Somogyi, A.; Bochner, F.
	2010	CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratification	Schroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.
	2006	The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo	Kirsch-Volders, M.; Mateuca, R.; Roelants, M.; Tremp, A.; Zeiger, E.; Bonassi, S.; Holland, N.; Chang, W.; Aka, P.; DeBoeck, M.; Godderis, L.; Haufroid, V.; Ishikawa, H.; Laffon, B.; Marcos, R.; Migliore, L.; Norppa, H.; Teixeira, J.; Zijno, A.; Fenech, M.